AtriCure, Inc.

ATRCNASDAQHealthcare● Active

$26.92

$-0.19(-0.68%)

Market Cap$1.4B

P/E Ratio—

52W High$43.18

52W Low$25.36

Avg Volume749K

Open$27.18

Beta1.26

Insider Trades Ownership Employees

AtriCure, Inc. (ATRC) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · ATRC · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

AtriCure, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

ATRC insider buying and selling by quarter

ATRC insider selling · ATRC insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

488K244K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · ATRC ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

ATRC executive sell shares · ATRC board member insider trading · ATRC insider trading SEC filing

Showing 94 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 20, 2026	Prange Karen Director	Sale	3,000	$28.65	$86K	26,373	Form 4
May 18, 2026	Prange Karen Director	Award	6,144	—	—	29,373	Form 4
May 18, 2026	Telman Deborah H Director	Award	6,144	—	—	28,328	Form 4
May 18, 2026	Yuen Maggie Director	Award	6,144	—	—	17,515	Form 4
May 18, 2026	Nachman Shlomo Director	Award	6,144	—	—	24,655	Form 4
May 18, 2026	JOHNSON B KRISTINE Director	Award	6,144	—	—	55,954	Form 4
May 18, 2026	GROVES REGINA E Director	Award	6,144	—	—	39,859	Form 4
May 18, 2026	WEHRWEIN SVEN Director	Award	6,144	—	—	40,518	Form 4
May 18, 2026	WHITE ROBERT S. Director	Award	6,144	—	—	128,318	Form 4
May 15, 2026	Doraiswamy Vinayak Chief Scientific Officer	Sale	5,000	$28.13	$141K	91,875	Form 4
Mar 12, 2026	Doraiswamy Vinayak Chief Scientific Officer	Sale	5,000	$29.83	$149K	96,875	Form 4
Mar 10, 2026	WHITE ROBERT S. Director	Option	10,000	$14.99	$150K	122,174	Form 4
Mar 6, 2026	CARREL MICHAEL H President, CEO, & Director	Gift	5,000	—	—	779,498	Form 4
Mar 6, 2026	CARREL MICHAEL H President, CEO, & Director	Gift	1,000	—	—	778,498	Form 4
Mar 1, 2026	CARREL MICHAEL H President, CEO, & Director	Award	101,280	—	—	857,275	Form 4
Mar 1, 2026	CARREL MICHAEL H President, CEO, & Director	Other	72,777	$31.26	$2.28M⚡	784,498	Form 4
Mar 1, 2026	CARREL MICHAEL H President, CEO, & Director	Award	68,618	—	—	755,995	Form 4
Mar 1, 2026	Noznesky Justin J Chief Mktg & Strategy Officer	Award	15,198	—	—	121,987	Form 4
Mar 1, 2026	Noznesky Justin J Chief Mktg & Strategy Officer	Award	27,991	—	—	106,789	Form 4
Mar 1, 2026	Noznesky Justin J Chief Mktg & Strategy Officer	Other	15,586	$31.26	$487K	106,401	Form 4
Mar 1, 2026	Privitera Salvatore Chief Technical Officer	Award	15,198	—	—	171,175	Form 4
Mar 1, 2026	Privitera Salvatore Chief Technical Officer	Other	13,127	$31.26	$410K	158,048	Form 4
Mar 1, 2026	Privitera Salvatore Chief Technical Officer	Award	30,390	—	—	155,977	Form 4
Mar 1, 2026	Doraiswamy Vinayak Chief Scientific Officer	Award	15,198	—	—	117,460	Form 4
Mar 1, 2026	Doraiswamy Vinayak Chief Scientific Officer	Award	30,390	—	—	102,262	Form 4

Prange Karen

Director

Sale

Date

May 20

3,000

Price

$28.65

Value

$86K

View Form 4 on SEC.gov

Prange Karen

Director

Award

Date

May 18

6,144

Price

—

Value

—

View Form 4 on SEC.gov

Telman Deborah H

Director

Award

Date

May 18

6,144

Price

—

Value

—

View Form 4 on SEC.gov

Yuen Maggie

Director

Award

Date

May 18

6,144

Price

—

Value

—

View Form 4 on SEC.gov

Nachman Shlomo

Director

Award

Date

May 18

6,144

Price

—

Value

—

View Form 4 on SEC.gov

JOHNSON B KRISTINE

Director

Award

Date

May 18

6,144

Price

—

Value

—

View Form 4 on SEC.gov

GROVES REGINA E

Director

Award

Date

May 18

6,144

Price

—

Value

—

View Form 4 on SEC.gov

WEHRWEIN SVEN

Director

Award

Date

May 18

6,144

Price

—

Value

—

View Form 4 on SEC.gov

WHITE ROBERT S.

Director

Award

Date

May 18

6,144

Price

—

Value

—

View Form 4 on SEC.gov

Doraiswamy Vinayak

Chief Scientific Officer

Sale

Date

May 15

5,000

Price

$28.13

Value

$141K

View Form 4 on SEC.gov

Doraiswamy Vinayak

Chief Scientific Officer

Sale

Date

Mar 12

5,000

Price

$29.83

Value

$149K

View Form 4 on SEC.gov

WHITE ROBERT S.

Director

Option

Date

Mar 10

10,000

Price

$14.99

Value

$150K

View Form 4 on SEC.gov

CARREL MICHAEL H

President, CEO, & Director

Gift

Date

Mar 6

5,000

Price

—

Value

—

View Form 4 on SEC.gov

CARREL MICHAEL H

President, CEO, & Director

Gift

Date

Mar 6

1,000

Price

—

Value

—

View Form 4 on SEC.gov

CARREL MICHAEL H

President, CEO, & Director

Award

Date

Mar 1

101,280

Price

—

Value

—

View Form 4 on SEC.gov

CARREL MICHAEL H

President, CEO, & Director

Other

Date

Mar 1

72,777

Price

$31.26

Value

$2.28M ⚡

View Form 4 on SEC.gov

CARREL MICHAEL H

President, CEO, & Director

Award

Date

Mar 1

68,618

Price

—

Value

—

View Form 4 on SEC.gov

Noznesky Justin J

Chief Mktg & Strategy Officer

Award

Date

Mar 1

15,198

Price

—

Value

—

View Form 4 on SEC.gov

Noznesky Justin J

Chief Mktg & Strategy Officer

Award

Date

Mar 1

27,991

Price

—

Value

—

View Form 4 on SEC.gov

Noznesky Justin J

Chief Mktg & Strategy Officer

Other

Date

Mar 1

15,586

Price

$31.26

Value

$487K

View Form 4 on SEC.gov

Privitera Salvatore

Chief Technical Officer

Award

Date

Mar 1

15,198

Price

—

Value

—

View Form 4 on SEC.gov

Privitera Salvatore

Chief Technical Officer

Other

Date

Mar 1

13,127

Price

$31.26

Value

$410K

View Form 4 on SEC.gov

Privitera Salvatore

Chief Technical Officer

Award

Date

Mar 1

30,390

Price

—

Value

—

View Form 4 on SEC.gov

Doraiswamy Vinayak

Chief Scientific Officer

Award

Date

Mar 1

15,198

Price

—

Value

—

View Form 4 on SEC.gov

Doraiswamy Vinayak

Chief Scientific Officer

Award

Date

Mar 1

30,390

Price

—

Value

—

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About ATRC insider trading

ATRC insider trades

AtriCure, Inc. (ATRC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including WEHRWEIN SVEN (Director), CARREL MICHAEL H (President, CEO, & Director), Doraiswamy Vinayak (Chief Scientific Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. ATRC insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For AtriCure, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

ATRC insider trading · 5 questions

The insiders of AtriCure, Inc. (ATRC) include executives and directors such as WEHRWEIN SVEN (Director), CARREL MICHAEL H (President, CEO, & Director), Doraiswamy Vinayak (Chief Scientific Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

ATRC board member insider tradingwho are ATRC insidersATRC insider rosterAtriCure, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026